scholarly journals Association of Vitamin D Insufficiency and Peripheral Vascular Resistance

2019 ◽  
Vol 04 (03) ◽  
pp. 142-145
Author(s):  
Chukkala Bharat Kumar Goud ◽  
Indrani Garre ◽  
S. Radhika

Abstract Background Vitamin D insufficiency is prevalent worldwide. Recently, the role of vitamin D substitution in hypertensive vitamin D deficient and insufficient patients has been studied by many investigators worldwide. In this observational study, the peripheral vascular resistance (PVR) of patients with vitamin D insufficiency or deficiency was analyzed. Objective The main purpose of this article is the assessment of PVR in vitamin D deficient subjects and in that any gender variation. Methods Subjects who were not known hypertensives, and who were free of other comorbidities, were included. Diabetic subjects were excluded. Serum vitamin D3 levels of all the subjects were recorded. Thirty-three subjects with serum vitamin D3 levels in insufficiency or deficiency range were included in our study. AGEDIO peripheral resistance calculator was used to calculate arterial stiffness indices, PVR, stroke volume, cardiac output, and cardiac index. Augmentation pressure (AG) is the contribution that wave reflection makes to systolic arterial pressure. Augmentation index (AI) is an indirect measure of arterial stiffness and is calculated as AG divided by pulse pressure ×100. Results The total number of subjects studied was 33, of whom 18 were males, and 15 were females. The mean serum vitamin D3 levels were 19.28 nanograms/mL. In this study, it was observed that the mean AI was 21.42 ± 12.6%, and mean pulse wave velocity was 6.9 ± 1.2 m/s. Among central hemodynamic measures, mean PVR was found to be 1733 ± 201.1dyn*s/cm5, mean cardiac output was 4.3 ± 0.5 L/min, and mean cardiac index was 2.56 +/– 0.33 L/mi*L/m2). Twenty-five (76%) patients showed increased PVR. Even though in patients with normal PVR, there is female preponderance, but in patients with high PVR, there was no gender difference. Conclusions This study has shown that the PVR was significantly high in vitamin D deficient and insufficient subjects (without hypertension or diabetes mellitus) with no significant gender difference for high PVR, even though AG and AI were not significantly different among subjects.

2021 ◽  
Author(s):  
Ying Lin ◽  
Huanjun Su ◽  
Jianbin Wu ◽  
Muzhi Yuan ◽  
Yong Zhang

Abstract Purpose: To assess the effect of oral vitamin D3 supplementation in dry eye after femtosecond laser-assisted in situ keratomileusis (FS-LASIK).Setting: Liuzhou Worker’s Hospital.Design: This prospective study included 90 patients selected between January and December in 2019, who underwent fs-lasik operation in our hospital and had obvious symptoms indicating dry eyes one month after operation. The subjects were randomly divided into two groups: the experimental group (n = 45) received vitamin D3 2000 IU / D continuously for 12 weeks; the control group (n = 45) did not take vitamin D3 orally. Ocular surface disease index(OSDI), tear breakup time(TBUT)and Schirmer’s Test I were evaluated pre-medication and 1,3,6 months after treatment. Serum vitamin D level, and the mean concentration of cytokine IL-6, IL-17, IL-23 in tears were also measured. Results: One month after treatment, the mean OSDI score of the experimental group (11.67 ± 8.53) was significantly lower than that of the control group (23.82 ± 13.22) (P = 0.007). TBUT (10.71±1.02s) and Schirmer I (9.36±0.40mm) of the experimental group were higher than those of the control group (7.49±1.29 s and 7.51±0.44 mm). The OSDI (10.25 ± 5.49), TBUT (10.75±1.09 seconds) and Schirmer I test value (11.34±0.39 mm) of the experimental group were significantly lower than those of the control group (20.22±6.23, 8.36±1.23, 8.12±0.50) at 3 months after treatment. There were significant differences in OSDI, TBUT (P < 0.05) and Schirmer I test value between the two groups at 6 months after treatment. Serum vitamin D3 level was negatively correlated with OSDI score (r=-0.90;P=0.00), and positively correlated with Schirmer I test (r=0.88;P=0.00), TBUT score (r=0.89;P=0.00) and TMH (r=0.80;P=0.00). IL-17 level was shown to be significantly correlated with TBUT (r=-0.25, P=0.014) and Schirmer I test (r=-0.21, P=0.018). IL-6 level was significantly correlated with OSDI (R=0.18, P = 0.020) and TBUT (R=0.20, P = 0.019).


Author(s):  
Abdulrahman Hefdhallah Amer ◽  
Kaushik Chaudhari ◽  
Riyaben Trivedi ◽  
Riddhi Patel

Background Vitamin D deficiency is a global health problem, and its role as an immune modulator has been recently tightened. The main role of vitamin D is to maintain calcium and phosphorus homeostasis, thus maintaining bone health. Recent evidence has shown that vitamin D may play a role in a variety disorders such as endocrine diseases, adrenal diseases, polycystic ovary syndrome and particular type 1 diabetes, type 2 diabetes. We evaluated the association between thyroid disorders (subclinical or overt hypothyroidism and subclinical or overt hyperthyroidism) and serum vitamin D3 level in the Indian population and its association with ionized calcium. Methods The cross-sectional study, included patients who visited Shree Krishna Hospital, Karamsad for thyroid evaluation or follow-up. We conducted this study involving a total of 84 individuals with normal thyroid function, were recorded as control. The cases group included 75 patients with hypothyroidism (overt or subclinical) and 10 patients with hyperthyroidism (overt or subclinical). Serum levels of vitamin D3, thyroid function and calcium ionized were measured in all adult subjects. Deficiency of vitamin D is defined as the level of vitamin D3 in the serum less than 50 nmol/L. Vitamin D insufficiency is defined as serum vitamin D3 level between 50 - 75 nmol/L. Vitamin D sufficiency is defined as serum Vit D3 level >75 nmol/L. Result The prevalence of vitamin D deficiency in subclinical and clinical hypothyroidism cases (36 of 40, 90%) was significantly higher than that observed in healthy individuals (0 of 40, 0%). The prevalence of vitamin D deficiency in subclinical and clinical hyperthyroidism cases (4 of 40, 10%). The prevalence of vitamin D insufficiency in subclinical and clinical hypothyroidism cases (24 of 62, 38.7%) was significantly lower than that observed in healthy individuals (controls) (35 of 62, 56.5%).The prevalence of vitamin D insufficiency in subclinical and clinical hyperthyroidism cases (3 of 62, 4.8%).  The prevalence of vitamin D sufficiency in subclinical and clinical hypothyroidism cases (15 of 67, 22.4%) was significantly lower than that observed in healthy individuals (controls) (49 of 67, 73.1 %). The prevalence of vitamin D sufficiency in subclinical and clinical hyperthyroidism cases (3 of 67, 4.5%). Conclusion Vitamin D deficiency was associated with hypothyroidism especially clinical hypothyroidism. Low serum levels of vitamin D3 were associated with high serum TSH levels. Keyword: Vitamin D3, calcium ionized, hypothyroidism and hyperthyroidism.


2020 ◽  
Author(s):  
Danial Alebouyeh ◽  
Nasrin Khalessi ◽  
Maryam Saboute ◽  
Maryam Alizadeh Chamkhaleh ◽  
Mandana Kashaki

Abstract Introduction. Vitamin D status is a key determinant of bone health and growth during childhood and adolescence. Therefore, we design a study to find out the association between the levels of serum vitamin D and need to consumption of vitamin D supplement.Method and materials. In this cross sectional study infants under 20 months referred to Ali Asghar Children's Hospital were included. Infants with maternal diseases and congenital malformations were excluded. All infants used vitamin D3 supplementation 400 IU per day from day fifth of birth. The level of 25-hydroxy vitamin D at the age of 1 years (month 12) were measured. Level of 25-hydroxy vitamin D in mothers were checked, too. Furthermore, we defined sufficient level of 25-hydroxy vitamin D ≥30ng/ml.Results. In this study, 68 infants under 20 months were examined. Half of them were boy. Mean age of infants was 16±3 months and mothers was 33±3 years old. In addition, the mean level of serum 25-hydroxy vitamin D in the infants were 40.99±13.86 ng/ml and in mothers were 31.39±13.14 ng/ml. 62.1% of mothers were in sufficient group and also 83% of infants had sufficient vitamin D level (25-hydroxy vitamin D ≥ 30ng/ml). There was not any significant correlation between vitamin D level in infants and mothers (P value=0.965). The mean level of serum vitamin D3 in boys was 39.55±3.79 ng/ml (12-51) and girls was 35.32±3.67 ng/ml (13.4-50). Similarly, significant relationship was not shown between gender and vitamin D of infants (P value = 0.437). Level of vitamin D in second children was significantly higher than first children (P value=0.011). The correlation between gestational age and vitamin D3 deficiency was also insignificant (P value=0.087). Head circumference (r= -0.404, P value=0.014) and age of mothers (r= 0.344, P value=0.04) correlated with vitamin D.Conclusion. In summary, we demonstrated most of the infants had sufficient vitamin D level at the age of 1 year. So it is recommended to continue vitamin D3 supplementation consumption.


2020 ◽  
Vol 24 (3) ◽  
pp. 395-400
Author(s):  
Dler Kakil ◽  
Mohammed Meena

Background and objective: Vitamin D deficiency appears to be related to the development of diabetes mellitus type 2 and metabolic syndrome. This study aimed to assess the association between the level of 25-hydroxy vitamin D{25(OH)D3 and the glycemic control in patients with type 2 diabetes. Methods: This case-control study involved 240 participants divided into two groups, 119 patients with type 2 diabetic mellitus and 120 healthy individuals as a control group. The study was conducted in Layla Qassim Diabetic Center in Erbil from March 2018 to March 2019. The data were collected from all the cases, including history and physical examination, using a specially designed questionnaire. From all cases, blood was taken, and samples were sent to the laboratory for serum vitamin D3 level estimation. Results: From the total of 240 participants, the mean age of cases was 54.04 ± 10.56 years and of controls was 53.12 ± 9.84 years. The mean serum vitamin D3 level of the cases was 9.21 ± 5.69ng/ml, and it was non-significantly (P = 0.3) higher than the control (8.61±4.57)ng/ml. Both groups were within the vitamin D deficient range. Vitamin D level was non-significantly deficient in 84 (70.6%) of diabetic patients compared to 89(73.6%) of control. There was a non-significant difference in vitamin D level in poorly controlled diabetic patients compared to well-controlled diabetic patients (P = 0.584). Conclusion: No significant association was detected between vitamin D level and glycemic control. Keywords: Type 2 diabetes mellitus; Vitamin D3 level; Glycemic control.


2017 ◽  
Vol 4 (3) ◽  
pp. 701
Author(s):  
Shambhu Prasad ◽  
Sharma B. P. ◽  
. Saurabh

Background: Osteoporosis is a serious, worldwide, and growing health problem; WHO has estimated the 30% of all women, older than 50 years (post-menopausal) has osteoporosis. Osteoporosis is a skeletal disorder characterized by compromised bone strength predisposing a person to an increased risk of fracture. Bone strength reflects the integration of two main features: bone density and bone quality.Methods: After clinical examination, patients were subjected to lab and radiological investigation as under: complete hemogram with ESR, serum calcium, phosphate, alkaline phosphatase, parathyroid hormone, 25 (OH) vitamin-D, KFT, LFT, DEXA scan. From above data, vitamin-D levels DEXA scan (t-score) was collected and statistically analysed.Results: 53 radiologically established cases by DEXA score (spine) of osteoporosis/osteopenia and 50 persons in control group of the age and sex match with normal DEXA score, presenting to OPD of central institute of orthopaedics, VMMC and Safdarjung Hospital were selected. The mean vitamin D3 level in cases was 19.37ng/ml with standard deviation of 10.2. Range of serum vitamin D3 levels in cases was from 7 to 51.2. Whereas mean vitamin D3 level in control group was 25.92 ng/ml with standard deviation of 7.24. Range of serum vitamin D3 levels in controls was from 10 to 35.5. The mean vitamin D levels of cases and control was 19.735±10.2 and 25.92±7.2 ng/ml respectively, these values were compared by using student t test and results were found to be statistically significant (P= 0.0001). The mean T score in spine cases was -2.59 with standard deviation of 0.92. Range of T score in cases was from -5.1 to -1. Whereas, mean T score in control group was -0.26 with standard deviation of 0.68. Range of T score in controls was from -0.9 to 1.4. The mean T score spine of cases and controls was -2.59±0.92 and -0.264±0.68 respectively, these values were compared by using student t test and results were found to be statistically significant (P = 0.0001).Conclusions: Study recommend that, vitamin D supplementation should be given to patients with osteopenia/osteoporosis. Further prospective studies to firmly establish the relationship between vitamin D and osteoporosis as well as evaluation of vitamin D supplementation in osteoporosis are needed.  


2018 ◽  
Author(s):  
Alexander Rodriguez ◽  
Cecilia Xu ◽  
Lachlan McMillan ◽  
Velandai Srikanth ◽  
David Scott ◽  
...  

Author(s):  
Sanjeeva Kumar Goud T ◽  
Rahul Kunkulol

The present study was aimed to study the effect of Sublingual Vitamin D3 on Serum Vitamin D level in Vitamin D deficiency patients. This was a cross-sectional and interventional study. All the Vitamin D deficiency patients of age 18-60years and either gender, willing to participate in the study were included. Patients who had greater than 20 ng/ml were excluded from the study. The total number of participants in our study was 200, out of these 111 males and 89 females, the mean age in our study was 51.07 ± 7.39Yrs. All volunteers were given sublingual vitamin D3 (60,000IU) in six doses every fifteen days of follow up for 3 months. The subject’s serum 25(OH)D levels were estimated before and after the treatment of sublingual vitamin D3. There was a statistically significant difference in serum vitamin D3 level before 16.61±6.71 ng/ml and after 35.80±7.80 ng/ml after treatment with Sublingual Vitamin D3. Six doses of 60,000IU of Vitamin D3 sublingual route having improved the role of serum 25(OH)D levels in the treatment of Vitamin D3 deficiency patients.Keywords: Vitamin D3; Sublingual route


2019 ◽  
Vol 16 (11) ◽  
pp. 1063-1071 ◽  
Author(s):  
Gonzague Foucault ◽  
Guillaume T Duval ◽  
Romain Simon ◽  
Olivier Beauchet ◽  
Mickael Dinomais ◽  
...  

Background: Vitamin D insufficiency is associated with brain changes, and cognitive and mobility declines in older adults. Method: Two hundred and fifteen Caucasian older community-dwellers (mean±SD, 72.1±5.5years; 40% female) received a blood test and brain MRI. The thickness of perigenual anterior cingulate cortex, midcingulate cortex and posterior cingulate cortex was measured using FreeSurfer from T1-weighted MR images. Age, gender, education, BMI, mean arterial pressure, comorbidities, use of vitamin D supplements or anti-vascular drugs, MMSE, GDS, IADL, serum calcium and vitamin B9 concentrations, creatinine clearance were used as covariables. Results: Participants with vitamin D insufficiency (n=80) had thinner total cingulate thickness than the others (24.6±1.9mm versus 25.3±1.4mm, P=0.001); a significant difference found for all 3 regions. Vitamin D insufficiency was cross-sectionally associated with a decreased total cingulate thickness (β=- 0.49, P=0.028). Serum 25OHD concentration correlated positively with the thickness of perigenual anterior (P=0.011), midcingulate (P=0.013) and posterior cingulate cortex (P=0.021). Conclusion: Vitamin D insufficiency was associated with thinner cingulate cortex in the studied sample of older adults. These findings provide insight into the pathophysiology of cognitive and mobility declines in older adults with vitamin D insufficiency.


1963 ◽  
Vol 44 (3) ◽  
pp. 430-442 ◽  
Author(s):  
B. Arner ◽  
P. Hedner ◽  
T. Karlefors ◽  
H. Westling

ABSTRACT Observations were made on healthy volunteers during insulin induced hypoglycaemia (10 cases) and infusion of adrenaline (3 cases) or cortisol (1 case). In all cases a rise in the cardiac output was registered during insulin hypoglycaemia. The mean arterial blood pressure was relatively unchanged and the calculated peripheral vascular resistance decreased in all cases. A temporary rise in plasma corticosteroids was observed. After infusion of adrenaline similar circulatory changes were observed but no rise in plasma corticosteroids was found. Infusion of cortisol caused an increased plasma corticosteroid level but no circulatory changes. It is concluded that liberation of catechol amines and increased adrenocortical activity following hypoglycaemia are not necessarily interdependent.


Sign in / Sign up

Export Citation Format

Share Document